YM BioSciences (YMI) says its buyout by a wholly owned subsidiary of Gilead Sciences (GILD...

|About: Gilead Sciences, Inc. (GILD)|By:, SA News Editor

YM BioSciences (YMI) says its buyout by a wholly owned subsidiary of Gilead Sciences (GILD +0.8%) has been endorsed by proxy advisory firms Institutional Investor Services and Glass, Lewis & Co. ISI says the all-cash deal offers a satisfactory premium, while Glass Lewis also notes that the YMI board of directors conducted a reasonable review of strategic alternatives available to the company prior to entering into the proposed agreement.